| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/84579 |
| P698 | PubMed publication ID | 11175837 |
| P2093 | author name string | Plate K | |
| P2860 | cites work | LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan | Q22008808 |
| Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) | Q24321792 | ||
| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| VEGF receptor signaling in tumor angiogenesis | Q33914422 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. | Q40827632 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases | Q64330833 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphangiogenesis | Q6708231 |
| angiogenesis | Q539568 | ||
| P1104 | number of pages | 2 | |
| P304 | page(s) | 151-152 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | From angiogenesis to lymphangiogenesis | |
| P478 | volume | 7 |
| Q28191040 | A model for gene therapy of human hereditary lymphedema |
| Q46974876 | Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells. |
| Q35687692 | Antiangiogenic strategies, compounds, and early clinical results in breast cancer |
| Q34066152 | Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. |
| Q38636009 | CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis. |
| Q36693212 | CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth |
| Q36552441 | Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis |
| Q36452704 | Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer |
| Q40368223 | Evaluation of stromal metalloproteinases and vascular endothelial growth factors in a spontaneous metastasis model |
| Q90589793 | Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer |
| Q38376244 | Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma |
| Q33778236 | Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106 |
| Q35181938 | Insights into the mechanisms of lymph node metastasis |
| Q40743580 | Interplays between genetic and environmental mechanisms trigger tumorigenic VEGF signalling in human HCC cell lines: pilot study |
| Q83464539 | Lymph node dissection in primary intrahepatic malignant mesothelioma: case report and implications for diagnosis and therapy |
| Q38122755 | Lymphatics and colorectal liver metastases: the case for sentinel node mapping |
| Q39293053 | Modeling Proteolytically Driven Tumor Lymphangiogenesis. |
| Q35026009 | Monoclonal antibodies as therapeutics in oncology |
| Q34576803 | Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma |
| Q24301631 | Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia |
| Q35855032 | New molecular targets for treatment of lymphoma |
| Q33977081 | Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects |
| Q50086993 | Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages |
| Q37021075 | Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer |
| Q34646656 | Recent advances in cancer research: mouse models of tumorigenesis |
| Q45752215 | Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma |
| Q37419274 | Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D. |
| Q39475329 | Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. |
| Q24307613 | The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells |
| Q36609889 | The role of the VEGF-C/VEGFR-3 axis in cancer progression |
| Q30981904 | Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial |
| Q34049659 | Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis |
Search more.